Trump unveils deals to lower prices of weight loss drugs DW 11/07/2025
The Trump administration secured discounts from Eli Lilly and Novo Nordisk for GLP-1 weight-loss drugs in exchange for tariff relief to reduce US drug costs.
Weight-loss drug makers announce pricing agreement with Trump
Agreement with Eli Lilly and Novo Nordisk cuts GLP-1 drug prices for Medicare, Medicaid, and cash payers, improving access and capping Medicare copays at $50.
